A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12 WEEK TRIAL TO EVALUATE THE EFFECT OF TIOTROPIUM INHALATION CAPSULES (SPIRIVA) ON THE MAGNITUDE OF EXERCISE, MEASURED USING AN ACCELEROMETER, IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD):